在非清晰细胞细胞癌的近期进展:生物学和治疗策略
Ahmet Yildirim1, Marcus W Moses2, Margo Gerke2
1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Therapeutic advances in medical oncology
|June 19, 2025
概括
非清细胞细胞癌 (nccRCC) 是一种罕见的癌,通常用清细胞RCC策略治疗. 分子表征方面的进步正在揭示开发更有效,更有针对性的nccRCC疗法的独特目标.
科学领域:
- 在瘤学瘤学.
- 生殖尿路病理学
- 分子诊断学 分子诊断
背景情况:
- 非清细胞细胞癌 (nccRCC) 是一种罕见且异质的癌群体,约占所有癌的20%.
- 目前对nccRCC的治疗通常依赖于针对清细胞细胞癌 (ccRCC) 开发的策略,由于不同的分子驱动因素,这种策略可能不是最佳的.
- 2022年世界卫生组织重新分类强调了分子和遗传标记在定义脏瘤亚型中的日益重要.
研究的目的:
- 提供关于非清细胞细胞癌亚型生物学和管理的最新进展的全面概述.
- 强调由nccRCC分子表征驱动的向疗法的不断变化的景观.
- 告知临床医生和研究人员关于基因标记在nccRCC诊断和治疗中的重要性.
主要方法:
- 关于nccRCC生物学和治疗的最新研究的文献综述.
- 对各种nccRCC亚型的分子和遗传发现的分析.
- 综合有关nccRCC新兴向疗法的信息.
主要成果:
- 最近对nccRCC的分子表征已经确定了新的治疗点.
- 针对nccRCC的特定分子驱动因素量身定制的向疗法的开发正在推进.
- 基因标记物的整合对于精确的脏瘤亚型和个性化治疗至关重要.
结论:
- 了解nccRCC亚型的独特分子形状对于有效治疗至关重要.
- 基于分子特征的向疗法为nccRCC管理提供了有前途的新途径.
- 不断变化的分类和诊断方法强调了在nccRCC中继续进行研究的必要性.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
9.1K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.3K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K